111 (YI) EBITDA Margin Growth (3y) (2020 - 2025)
111 (YI) EBITDA Margin Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 100.02 Bn | 94.85 Bn | 3.69 Bn | -23.00 |
| 2 | Cencora | 60.88 Bn | 58.06 Bn | 3.61 Bn | 35.00 |
| 3 | Cardinal Health | 54.14 Bn | 49.29 Bn | 2.56 Bn | 84.00 |
| 4 | Henry Schein | 10.05 Bn | 9.90 Bn | 1.10 Bn | -154.00 |
| 5 | Akso Health | 737.16 Mn | 736.96 Mn | - | - |
| 6 | Edap Tms | 159.12 Mn | 137.58 Mn | 7.34 Mn | -3,120.00 |
| 7 | Accendra Health | 100.85 Mn | 93.20 Mn | 263.41 Mn | -615.00 |
| 8 | 111 | 32.10 Mn | -26.65 Mn | 18.18 Mn | -25.00 |
| 9 | Cosmos Health | 12.73 Mn | 10.29 Mn | 1.51 Mn | 501.00 |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | 14,001.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 260.00 |
| Sep 30, 2025 | 233.00 |
| Jun 30, 2025 | 263.00 |
| Mar 31, 2025 | 343.00 |
| Dec 31, 2024 | 283.00 |
| Sep 30, 2024 | 531.00 |
| Jun 30, 2024 | 634.00 |
| Mar 31, 2024 | 678.00 |
| Dec 31, 2023 | 45.00 |
| Sep 30, 2023 | 298.00 |
| Jun 30, 2023 | 453.00 |
| Mar 31, 2023 | 663.00 |
| Dec 31, 2022 | -1,508.00 |
| Sep 30, 2022 | -1,304.00 |
| Jun 30, 2022 | -1,466.00 |
| Mar 31, 2022 | 1,272.00 |
| Dec 31, 2021 | -2,674.00 |
| Sep 30, 2021 | -3,135.00 |
| Jun 30, 2021 | 1,773.00 |
| Mar 31, 2021 | 609.00 |